The root of Ceva Animal Health USA lies in Biomune, the vaccine manufacturing company in Lenexa, Kansas it acquired in 2005.
“When we originally purchased Ceva Biomune we had a vision for where this (company) could go,” said Daryl Pint, Ceva Biomune CEO, during a tour of the facilities for swine industry media. “Ceva has purchased 27 companies over the last 15 years so we understand how to incorporate these companies and we understand how to grow within the market.”
Pint says Ceva’s goal is to grow its swine business as much in the next five years as the company has grown in the last 15, and a new expansion of the facilities in Lenexa will help to achieve that. “The 35,000 square foot expansion is the first of many,” he said. “Every year there is another capitol project to meet the growing demand for our products.”
Learn more about Ceva Biomune in this interview: Interview with Daryl Pint, Ceva Biomune CEO